Get startedLog in
    Picture of Sumitomo Pharma logo

    4506 — Sumitomo Pharma News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapValue Trap
    All News

    Dsp-5336 Received U.S. FDA Fast-Track Designation For The Treatment Of Relapsed Or Refractory Acute Myeloid Leukemia

    Picture of Sumitomo Pharma logoSumitomo Pharma
    16/07/2024 03:43
    July 16 (Reuters) - Sumitomo Pharma Co Ltd  4506.T :
    * SUMITOMO PHARMA CO LTD: DSP-5336 RECEIVED U.S. FDA
FAST-TRACK
DESIGNATION  FOR THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE
MYELOID LEUKEMIA

Source text for Eikon:  ID:nTSsp862c8 
Further company coverage:  4506.T 

 (Reporting by Tokyo Newsroom)
 ((+81345201189;))

    Recent news on Sumitomo Pharma

    See all news